Skip to main content

Table 1 Multivariate analysis for overall survival (n = 1661)

From: Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcome

 

HR

95% CI

P value

Tumor mutational burden

≤ 10 mutation/Mb

1.47

[1.2–1.8]

< 0.0001

>  10 mutation/mb

1

 

Cancer Type

Bladder

1.04

[0.8–1.3]

< 0.0001

Melanoma

0.55

[0.4–0.7]

NSCLC

1.3

[1.1–1.5]

Other

1

 

BAF/PBAF mutational status

Wild-type

1.2

[1.05–1.4]

0.017

Mutated

1

 
Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us